Kairos Pharma (KAPA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.60, -10.39% vs the prior close of $0.67.
- Volume 133.74K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KAPA slides 10.4% to $0.60, a 52-week low, 4 down days in a row. Closed at $0.60, -10.39% vs the prior close of $0.67. Day range $0.60–$0.69, opened at $0.69.
KAPA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KAPA slides 10.4% to $0.60, a 52-week low, 4 down days in a row
- Closed at $0.60, -10.39% vs the prior close of $0.67. Day range $0.60–$0.69, opened at $0.69.
- Volume was 133.74K shares, 0.3x its 50-day average of 443.10K — lighter than usual.
- Price is -64.4% vs its 50-day average ($1.69) and -81.8% vs its 200-day average ($3.31).
- 52-week range $0.60–$8.96; today's close sits at 0% of that range, 93.3% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — KAPA slides 9.7% to $0.67, a 52-week low, 3 down days in a row
- Closed at $0.67, -9.69% vs the prior close of $0.74. Day range $0.66–$0.73, opened at $0.72.
- Volume was 253.20K shares, 0.6x its 50-day average of 440.60K — lighter than usual.
- Price is -61.3% vs its 50-day average ($1.73) and -79.8% vs its 200-day average ($3.33).
- 52-week range $0.66–$9.17; today's close sits at 0% of that range, 92.7% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — KAPA slides 10.4% to $0.74, a 52-week low
- Closed at $0.74, -10.37% vs the prior close of $0.83. Day range $0.71–$0.80, opened at $0.80.
- Volume was 285.50K shares, 0.7x its 50-day average of 436.26K.
- Price is -57.9% vs its 50-day average ($1.77) and -77.8% vs its 200-day average ($3.35).
- 52-week range $0.71–$9.17; today's close sits at 0% of that range, 91.9% below the 52-week high.
Oct 13, 2026 — KAPA dips 0.4% to $0.83
- Closed at $0.83, -0.36% vs the prior close of $0.83. Day range $0.78–$0.84, opened at $0.83.
- Volume was 155.30K shares, 0.4x its 50-day average of 434.39K — lighter than usual.
- Price is -53.9% vs its 50-day average ($1.80) and -75.4% vs its 200-day average ($3.37).
- 52-week range $0.74–$9.17; today's close sits at 1% of that range, 91.0% below the 52-week high.
Oct 12, 2026 — KAPA rises 2.7% to $0.83
- Closed at $0.83, +2.72% vs the prior close of $0.81. Day range $0.74–$0.84, opened at $0.81.
- Volume was 251.00K shares, 0.6x its 50-day average of 436.29K — lighter than usual.
- Price is -54.4% vs its 50-day average ($1.82) and -75.5% vs its 200-day average ($3.39).
- 52-week range $0.74–$9.24; today's close sits at 1% of that range, 91.0% below the 52-week high.
Oct 9, 2026 — KAPA slides 15.6% to $0.81, a 52-week low
- Closed at $0.81, -15.62% vs the prior close of $0.96. Day range $0.78–$1.00, opened at $0.91.
- Volume was 637.80K shares, 1.5x its 50-day average of 427.45K.
- Price is -56.2% vs its 50-day average ($1.85) and -76.3% vs its 200-day average ($3.42).
- 52-week range $0.78–$9.59; today's close sits at 0% of that range, 91.6% below the 52-week high.
Oct 8, 2026 — KAPA jumps 10.3% to $0.96 on 18.7x normal volume
- Closed at $0.96, +10.34% vs the prior close of $0.87. Day range $0.92–$1.25, opened at $0.93.
- Volume was 5.82M shares, 18.7x its 50-day average of 312.06K — unusually heavy trading.
- Price is -48.8% vs its 50-day average ($1.88) and -72.1% vs its 200-day average ($3.44).
- 52-week range $0.85–$9.59; today's close sits at 1% of that range, 90.0% below the 52-week high.
Oct 7, 2026 — KAPA slides 24.3% to $0.87, a 52-week low on 3.8x normal volume
- Closed at $0.87, -24.35% vs the prior close of $1.15. Day range $0.85–$1.14, opened at $1.09.
- Volume was 1.10M shares, 3.8x its 50-day average of 290.93K — unusually heavy trading.
- Price is -54.2% vs its 50-day average ($1.90) and -74.9% vs its 200-day average ($3.46).
- 52-week range $0.85–$9.59; today's close sits at 0% of that range, 90.9% below the 52-week high.
- That makes 9 straight losses.
Oct 6, 2026 — KAPA slides 25.8% to $1.15, a 52-week low on 106.2x normal volume
- Closed at $1.15, -25.81% vs the prior close of $1.55. Day range $1.06–$2.16, opened at $1.59.
- Volume was 9.94M shares, 106.2x its 50-day average of 93.61K — unusually heavy trading.
- Price is -40.2% vs its 50-day average ($1.92) and -67.0% vs its 200-day average ($3.49).
- 52-week range $1.06–$9.59; today's close sits at 1% of that range, 88.0% below the 52-week high.
- That makes 8 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — KAPA dips 0.6% to $1.55, a 52-week low, 7 down days in a row
- Closed at $1.55, -0.64% vs the prior close of $1.56. Day range $1.52–$1.59, opened at $1.55.
- Volume was 19.10K shares, 0.2x its 50-day average of 97.48K — lighter than usual.
- Price is -20.3% vs its 50-day average ($1.94) and -55.8% vs its 200-day average ($3.51).
- 52-week range $1.47–$9.59; today's close sits at 1% of that range, 83.8% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — KAPA ends flat (+0.0%) to $1.56, 6 down days in a row
- Closed at $1.56, +0.00% vs the prior close of $1.56. Day range $1.53–$1.62, opened at $1.61.
- Volume was 25.80K shares, 0.3x its 50-day average of 101.80K — lighter than usual.
- Price is -20.1% vs its 50-day average ($1.95) and -55.7% vs its 200-day average ($3.53).
- 52-week range $1.47–$9.59; today's close sits at 1% of that range, 83.7% below the 52-week high.
- That makes 6 straight losses.
KAPA latest news & SEC filings
Every SEC filing by or about KAPA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.39M (prior year -$1.42M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.06 (prior year -$0.08) (loss narrowed vs Jun 30, 2025)
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade KAPA
- How much it moves: over the last 20 sessions the average daily move was 6.59% (largest 25.8%). That is a volatile stock.
- Liquidity: about 984.29K shares (≈$591.85K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.60 vs a range of $0.60–$8.96 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:7 on Sep 1, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 14, 2026; 8-K Aug 21, 2026.
- Share count: 23.70M shares outstanding (Aug 12, 2026), +14.2% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
KAPA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.69 | 0.69 | 0.60 | 0.60 | 133.74K |
| Oct 15, 2026 | 0.72 | 0.73 | 0.66 | 0.67 | 253.20K |
| Oct 14, 2026 | 0.80 | 0.80 | 0.71 | 0.74 | 285.50K |
| Oct 13, 2026 | 0.83 | 0.84 | 0.78 | 0.83 | 155.30K |
| Oct 12, 2026 | 0.81 | 0.84 | 0.74 | 0.83 | 251.00K |
| Oct 9, 2026 | 0.91 | 1.00 | 0.78 | 0.81 | 637.80K |
| Oct 8, 2026 | 0.93 | 1.25 | 0.92 | 0.96 | 5.82M |
| Oct 7, 2026 | 1.09 | 1.14 | 0.85 | 0.87 | 1.10M |
| Oct 6, 2026 | 1.59 | 2.16 | 1.06 | 1.15 | 9.94M |
| Oct 5, 2026 | 1.55 | 1.59 | 1.52 | 1.55 | 19.10K |
| Oct 2, 2026 | 1.61 | 1.62 | 1.53 | 1.56 | 25.80K |
| Oct 1, 2026 | 1.59 | 1.65 | 1.47 | 1.56 | 79.10K |
| Sep 30, 2026 | 1.71 | 1.78 | 1.60 | 1.64 | 99.30K |
| Sep 29, 2026 | 1.68 | 1.75 | 1.64 | 1.66 | 50.90K |
| Sep 28, 2026 | 1.74 | 1.80 | 1.65 | 1.68 | 51.80K |
| Sep 25, 2026 | 1.77 | 1.78 | 1.72 | 1.72 | 42.30K |
| Sep 24, 2026 | 1.70 | 1.82 | 1.70 | 1.77 | 299.90K |
| Sep 23, 2026 | 1.75 | 1.78 | 1.70 | 1.73 | 63.40K |
| Sep 22, 2026 | 1.78 | 1.81 | 1.70 | 1.78 | 247.10K |
| Sep 21, 2026 | 1.75 | 1.80 | 1.70 | 1.79 | 126.40K |
About Kairos Pharma
Kairos Pharma (KAPA) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1962011.
KAPA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hyun W. Bae | Director | Dec 23, 2025 |
| Hansoo Michael Keyoung | Director | Nov 26, 2025 |
| Rahul Singhvi | Director | Nov 26, 2025 |
| John S Yu | CEO and Chairman | Nov 26, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Neil Bhowmick | Chief Scientific Officer | Dec 30, 2025 |
| Ramachandran Murali | VP of Research and Development | Nov 26, 2025 |
| Doug Samuelson | Chief Financial Officer | Nov 26, 2025 |
| John S Yu | CEO and Chairman | Nov 26, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
KAPA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-5.45M | -0.30 | $-3.44M |
| Dec 31, 2024 | — | $-2.60M | -0.23 | $-3.96M |
| Dec 31, 2023 | — | $-1.81M | -0.17 | $81.00K |
Latest balance sheet: total assets $4.46M, total liabilities $992.00K, cash $2.63M (as of Jun 30, 2026).
KAPA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KAPA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.